SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Spadaro, A
Right arrow Articles by Zoppinia, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spadaro, A
Right arrow Articles by Zoppinia, A
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus

A Spadaro

Department of Medical Therapy, Rheumatology Unit, University of Rome "La Sapienza", Rome, Italy; Dipartimento di Terapia Medica, Divisione di Reumatologia, Universitá di Roma "La Sapienza", Azienda Policlinico Umberto I, Viale del Policlinico 155, 00151 Rome, Italy Tel/fax: (+39) 6 4462013

V Riccieri

S Terracina

T Rinaldi

E Taccari

A Zoppinia

Department of Medical Therapy, Rheumatology Unit, University of Rome "La Sapienza", Rome, Italy

The relationship of rheumatoid factors (RF) with antiphospholipid syndrome (aPLS) and anticardiolipin antibodies (aCL) has rarely been investigated in systemic lupus erythematosus (SLE). We found IgM-RF, IgG-RF, IgA-RF, IgM-aCL, IgG-aCL, IgA-aCL, respectively, in 35.4%, 35.4%, 33.8%, 23.1%, 23.1%, 20.0% of 65 SLE patients. Class specific RFs were negatively associated (P < 0.05) with IgG-aCL. The frequency of definite or probable aPLS according to Alarcon-Segovia classification criteria was significantly (P < 0.05) different (8.7% vs 30.9%) in patients with or without IgG-RF. Among the other clinical features of SLE, we found that patients with IgG-RF, compared to patients lacking this autoantibody, showed a lower frequency (P < 0.05) of serositis (21.7% vs 52.4%) and hematologic (52.2% vs 80.9%) disorders. The levels of IgG-RF and IgM-RF negatively correlated with the number of ARA criteria (P < 0.05) but not with the indices of diseases activity or damage. Our study shows that in SLE the presence of RFs are not markers of severity of the disease, but the negative association between IgG-RF and IgG-aCL suggests a distinct role of these autoantibodies in the pathology of SLE, whereas the presence of IgG isotype may identify a subset of SLE patients having a lower risk to develop some clinical manifestations such as aPLS.

Key Words: rheumatoid factors • anticardiolipin antibodies • antiphospholipid syndrome

Lupus, Vol. 9, No. 1, 56-60 (2000)
DOI: 10.1177/096120330000900110


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
J A Simon, J Granados, J Cabiedes, J R. Morales, and J A. Varela
Clinical and immunogenetic characterization of Mexican patients with 'Rhupus'
Lupus, May 1, 2002; 11(5): 287 - 292.
[Abstract] [PDF]



Advertisement